Annual Total Assets
$205.80 M
-$42.14 M-17.00%
December 31, 2023
Summary
- As of February 7, 2025, ESPR annual total assets is $205.80 million, with the most recent change of -$42.14 million (-17.00%) on December 31, 2023.
- During the last 3 years, ESPR annual total assets has fallen by -$147.46 million (-41.74%).
- ESPR annual total assets is now -46.07% below its all-time high of $381.59 million, reached on December 31, 2021.
Performance
ESPR Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$314.11 M
-$38.20 M-10.84%
September 30, 2024
Summary
- As of February 7, 2025, ESPR quarterly total assets is $314.11 million, with the most recent change of -$38.20 million (-10.84%) on September 30, 2024.
- Over the past year, ESPR quarterly total assets has dropped by -$38.20 million (-10.84%).
- ESPR quarterly total assets is now -17.68% below its all-time high of $381.59 million, reached on December 31, 2021.
Performance
ESPR Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
ESPR Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.0% | -10.8% |
| 3 y3 years | -41.7% | -10.8% |
| 5 y5 years | +43.5% | +23.1% |
ESPR Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.1% | at low | -17.7% | +52.6% |
| 5 y | 5-year | -46.1% | at low | -17.7% | +74.9% |
| alltime | all time | -46.1% | +9341.5% | -17.7% | +4195.6% |
Esperion Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $314.11 M(-10.8%) |
| Jun 2024 | - | $352.32 M(-5.6%) |
| Mar 2024 | - | $373.06 M(+81.3%) |
| Dec 2023 | $205.80 M(-17.0%) | $205.80 M(-7.0%) |
| Sep 2023 | - | $221.31 M(-5.7%) |
| Jun 2023 | - | $234.63 M(-6.8%) |
| Mar 2023 | - | $251.82 M(+1.6%) |
| Dec 2022 | $247.94 M(-35.0%) | $247.94 M(-20.7%) |
| Sep 2022 | - | $312.83 M(+2.9%) |
| Jun 2022 | - | $303.98 M(-11.3%) |
| Mar 2022 | - | $342.85 M(-10.2%) |
| Dec 2021 | $381.59 M(+8.0%) | $381.59 M(+69.4%) |
| Sep 2021 | - | $225.26 M(-19.7%) |
| Jun 2021 | - | $280.46 M(+0.7%) |
| Mar 2021 | - | $278.61 M(-21.1%) |
| Dec 2020 | $353.26 M(+64.7%) | $353.26 M(+40.8%) |
| Sep 2020 | - | $250.97 M(-24.0%) |
| Jun 2020 | - | $330.35 M(+83.9%) |
| Mar 2020 | - | $179.64 M(-16.2%) |
| Dec 2019 | $214.45 M(+49.5%) | $214.45 M(-16.0%) |
| Sep 2019 | - | $255.27 M(-17.3%) |
| Jun 2019 | - | $308.81 M(+30.6%) |
| Mar 2019 | - | $236.48 M(+64.9%) |
| Dec 2018 | $143.45 M | $143.45 M(-17.6%) |
| Sep 2018 | - | $174.03 M(-17.5%) |
| Jun 2018 | - | $210.88 M(-13.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $244.19 M(-12.1%) |
| Dec 2017 | $277.83 M(+13.3%) | $277.83 M(-11.3%) |
| Sep 2017 | - | $313.09 M(+69.0%) |
| Jun 2017 | - | $185.24 M(-13.7%) |
| Mar 2017 | - | $214.61 M(-12.5%) |
| Dec 2016 | $245.21 M(-17.0%) | $245.21 M(-7.0%) |
| Sep 2016 | - | $263.79 M(-4.9%) |
| Jun 2016 | - | $277.47 M(-3.0%) |
| Mar 2016 | - | $286.04 M(-3.2%) |
| Dec 2015 | $295.57 M(+106.3%) | $295.57 M(-3.5%) |
| Sep 2015 | - | $306.39 M(-3.0%) |
| Jun 2015 | - | $315.96 M(-2.8%) |
| Mar 2015 | - | $325.22 M(+127.0%) |
| Dec 2014 | $143.28 M(+83.0%) | $143.28 M(+136.7%) |
| Sep 2014 | - | $60.53 M(-12.6%) |
| Jun 2014 | - | $69.29 M(-1.3%) |
| Mar 2014 | - | $70.22 M(-10.3%) |
| Dec 2013 | $78.29 M(+970.7%) | $78.29 M(-9.6%) |
| Sep 2013 | - | $86.58 M(+343.2%) |
| Jun 2013 | - | $19.53 M(-12.3%) |
| Mar 2013 | - | $22.27 M(+204.5%) |
| Dec 2012 | $7.31 M(+235.5%) | $7.31 M |
| Dec 2011 | $2.18 M(-95.8%) | - |
| Dec 2002 | $51.41 M(-34.4%) | - |
| Dec 2001 | $78.34 M(+0.6%) | - |
| Dec 2000 | $77.88 M(+873.6%) | - |
| Dec 1999 | $8.00 M | - |
FAQ
- What is Esperion Therapeutics annual total assets?
- What is the all time high annual total assets for Esperion Therapeutics?
- What is Esperion Therapeutics annual total assets year-on-year change?
- What is Esperion Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly total assets year-on-year change?
What is Esperion Therapeutics annual total assets?
The current annual total assets of ESPR is $205.80 M
What is the all time high annual total assets for Esperion Therapeutics?
Esperion Therapeutics all-time high annual total assets is $381.59 M
What is Esperion Therapeutics annual total assets year-on-year change?
Over the past year, ESPR annual total assets has changed by -$42.14 M (-17.00%)
What is Esperion Therapeutics quarterly total assets?
The current quarterly total assets of ESPR is $314.11 M
What is the all time high quarterly total assets for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly total assets is $381.59 M
What is Esperion Therapeutics quarterly total assets year-on-year change?
Over the past year, ESPR quarterly total assets has changed by -$38.20 M (-10.84%)